Aarti Drugs reports Rs 721.1 crore revenue in Q4 FY26 with 6% YoY growth – Business Upturn
Aarti Drugs Limited, a diversified pharmaceutical company based in Mumbai, announced its audited financial results for the fourth quarter and financial year ending 31st March 2026. The company reported a consolidated revenue of ₹721.1 crore for Q4 FY26, marking a 6% year-on-year increase from ₹678.6 crore in Q4 FY25 and a 20% quarter-on-quarter rise from ₹602.9 crore in Q3 FY26.…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
